417 top medical experts on Hemangioendothelioma across 50 countries and 28 U.S. states, including 316 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hemangioendothelioma: A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hemangioma (2,319) and Narrower Categories: Epithelioid Hemangioendothelioma (2,115).
  4. Clinical Trials ClinicalTrials.gov : at least 24 including 1 Active, 4 Completed, 14 Recruiting


  

        

                    


    Computing Expert Listing ...

);